Virtus Investment Advisers, Inc. Gilead Sciences, Inc. Transaction History

Virtus Investment Advisers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $220,048 - $250,996	-2,895 Reduced 50.12%	2,881 $222,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $343,903 - $392,825	5,776 New	5,776 $356,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $404,844 - $493,550	-5,558 Closed	0 $0
Q4 2017 Feb 26, 2018	SELL	$71.15 - $83.52 $1.53 Million - $1.8 Million	-21,574 Reduced 79.51%	5,558 $398,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.93 Million - $2.27 Million	27,132	27,132 $400,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.